Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update reports Phase 1 results on veliparib, evaluating safety, pharmacokinetics, and oral bioavailability in subjects with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• High-grade Serous Ovarian Cancer

Drugs mentioned

• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Oncology, BRCA Mutated | Phase 1 | Status: COMPLETED